Recent Quotes (30 days)

You have no recent quotes
chg | %

Verisante Technology Inc  

(Public, CVE:VRS)   Watch this stock  
Find more results for CVE:THZ
0.0000 (0.00%)
Delayed:   10:10AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.06 - 0.06
52 week 0.06 - 0.16
Open 0.06
Vol / Avg. 1,000.00/55,199.00
Mkt cap 5.95M
P/E     -
Div/yield     -
EPS -0.03
Shares 91.51M
Beta 1.01
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -527.87% -1477.66%
Operating margin -497.01% -1537.63%
EBITD margin - -1012.74%
Return on average assets -40.34% -63.67%
Return on average equity -68.30% -81.66%
Employees 8 -
CDP Score - -


Suite 306 - 2309 West 41st Avenue
+1-604-6050507 (Phone)
+1-604-6050508 (Fax)

Website links


Verisante Technology, Inc. is a Canada-based medical device company. The Company is engaged in commercializing systems for the early detection of cancer. The Company's device portfolio includes Verisante Aura, Verisante Core and Verisante MSI Camera. Verisante Aura is a Raman spectroscopy system, designed for the early detection of all forms of skin cancer, including basal cell and squamous cell carcinoma and melanoma. The system provides diagnosis information by identifying spectral changes associated with the biochemistry of skin cancer cells in less than a second; providing immediate results. The Verisante Core is a medical equipment for the early detection of cancers including lung, colon and cervical, using an endoscopic attachment. Verisante MSI Camera is a rapid MSI imaging system, which captures images of 18 different narrow band wavelengths of light in one third of a second to capture multispectral images, which assist in oral and skin cancer detection applications.

Officers and directors

Thomas A. Braun President, Chief Executive Officer, Chief Business Development Officer, Director
Anna Trinh Chief Financial Officer, Vice President - Administration, Corporate Counsel, Secretary
Joseph Biegel Independent Director
Karen Boodram Independent Director
Age: 49
Christopher John Wesley Dennis Independent Director
Jake J. Thiessen Ph.D. Independent Director
Age: 66